“Clinical and Metabolic Determinants of Hepatic Fibrosis in Patients With Metabolic Dysfunction- Associated Steatotic Liver Disease (MASLD) – Insights from a Bangladeshi Cohort”. 2025. The Insight 8 (03): 588-92. https://doi.org/10.5281/zenodo.18014065.